Cargando…

c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential

Although the etiology of Parkinson’s disease (PD) is poorly understood, oxidative stress has long been implicated in the pathogenesis of the disease. However, multifaceted and divergent signaling cascades downstream of oxidative stress have posed challenges for researchers to identify a central com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brahmachari, Saurav, Karuppagounder, Senthilkumar S., Ge, Preston, Lee, Saebom, Dawson, Valina L., Dawson, Ted M., Ko, Han Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676866/ https://www.ncbi.nlm.nih.gov/pubmed/29103051 http://dx.doi.org/10.3233/JPD-171191

Ejemplares similares

The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
por: Karuppagounder, Senthilkumar S., et al.
Publicado: (2014)

Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons
por: Kumar, Manoj, et al.
Publicado: (2020)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
por: Yun, Seung Pil, et al.
Publicado: (2018)

The cell biology of Parkinson’s disease
por: Panicker, Nikhil, et al.
Publicado: (2021)

STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
por: Hinkle, Jared T., et al.
Publicado: (2022)

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
por: Ge, Preston, et al.
Publicado: (2020)

Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
por: Xiong, Yulan, et al.
Publicado: (2017)

DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease
por: Yazar, Volkan, et al.
Publicado: (2023)

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
por: Yun, Seung Pil, et al.
Publicado: (2018)

Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons
por: Xue, Yingchao, et al.
Publicado: (2018)

Sulfhydration mediates neuroprotective actions of parkin
por: Vandiver, M. Scott, et al.
Publicado: (2013)

PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
por: Pirooznia, Sheila K., et al.
Publicado: (2020)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Parthanatos Mediates AIMP2 Activated Age Dependent Dopaminergic Neuronal Loss
por: Lee, Yunjong, et al.
Publicado: (2013)

The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model
por: Lee, Saebom, et al.
Publicado: (2018)

c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation
por: Lee, Saebom, et al.
Publicado: (2022)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
por: Gu, Hao, et al.
Publicado: (2021)

Pharmacologic inhibition of MIF nuclease: A new treatment paradigm to treat cell death
por: Biswas, Devanik, et al.
Publicado: (2022)

A high-affinity cocaine binding site associated with the brain acid soluble protein 1
por: Harraz, Maged M., et al.
Publicado: (2022)

Waiting for PARIS—A Biological Target in Search of a Drug: PARIS farnesylation: Considerations in addressing a new biological target for neuroprotection in patients with Parkinson’s disease
por: Wyse, Richard K., et al.
Publicado: (2022)

The interplay of microRNA and neuronal activity in health and disease
por: Eacker, Stephen M., et al.
Publicado: (2013)

Targeting Parthanatos in Ischemic Stroke
por: Koehler, Raymond C., et al.
Publicado: (2021)

Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons
por: Jiang, Haisong, et al.
Publicado: (2016)

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010)

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily
por: Stafa, Klodjan, et al.
Publicado: (2014)

Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
por: Yin, Xiling, et al.
Publicado: (2021)

Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation
por: Yazar, Volkan, et al.
Publicado: (2021)

Recent advances in preventing neurodegenerative diseases
por: Chou, Shih-Ching, et al.
Publicado: (2021)

Neuronal Activity Regulates Hippocampal miRNA Expression
por: Eacker, Stephen M., et al.
Publicado: (2011)

Functional Identification of Neuroprotective Molecules
por: Dai, Cheng, et al.
Publicado: (2010)

MiR-223 regulates the differentiation of immature neurons
por: Harraz, Maged M, et al.
Publicado: (2014)

Lysosomal Enzyme Glucocerebrosidase Protects against Aβ(1-42) Oligomer-Induced Neurotoxicity
por: Choi, Seulah, et al.
Publicado: (2015)

Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
por: Park, Jong-Sung, et al.
Publicado: (2021)

Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release
por: Yu, Seong-Woon, et al.
Publicado: (2009)

Neurons Derived from Human Induced Pluripotent Stem Cells Integrate into Rat Brain Circuits and Maintain Both Excitatory and Inhibitory Synaptic Activities
por: Yin, Xiling, et al.
Publicado: (2019)

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
por: Lindholm, Dan, et al.
Publicado: (2016)

Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid
por: Na, Chan Hyun, et al.
Publicado: (2020)

Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains
por: Kim, Jungwoo Wren, et al.
Publicado: (2021)

The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model
por: Marín, Tamara, et al.
Publicado: (2022)

Dynamic and redundant regulation of LRRK2 and LRRK1 expression
por: Biskup, Saskia, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_338cpusp7j58cbou0r5cm65o8m